6. Analysed the core values, mission and vision statement, resources and capabilities,
stakeholder analysis and engagement, organisation culture of Pfizer. This project report explains the current status of Pfizer in Ireland and future business strategy for business growth. By analyzing PESTEL and SWOT, the report provides a recommendation for the future business strategy for Pfizer to reduce weaknesses in the market.
Based on the consumer segment of Johnson & Johnson, we analysed the current situation of the company and came up with strategic recommendations on how it can enhance its position in the market.
Strategic Management Case of Pfizer. From text book by David, Fred R. "Strategic Management Concepts & Cases",13 th Ed. Assignment on Strategic Management Class in Universitas Tarumanegara Post Graduate class.
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Our mission is to discover new ways to improve and extend people’s lives. Our vision is to be a trusted leader in changing the practice of medicine.
Sun pharma- A complete company review, analysis of crisis and realistic recom...TilikaChawda
Sun pharma has been the most talked about Indian pharma company for being in the news several times for its unresolved issues with the US FDA regarding the Halol and Mohali plant.
This presentation has analysed the situation and it suggests various solutions for the same.
6. Analysed the core values, mission and vision statement, resources and capabilities,
stakeholder analysis and engagement, organisation culture of Pfizer. This project report explains the current status of Pfizer in Ireland and future business strategy for business growth. By analyzing PESTEL and SWOT, the report provides a recommendation for the future business strategy for Pfizer to reduce weaknesses in the market.
Based on the consumer segment of Johnson & Johnson, we analysed the current situation of the company and came up with strategic recommendations on how it can enhance its position in the market.
Strategic Management Case of Pfizer. From text book by David, Fred R. "Strategic Management Concepts & Cases",13 th Ed. Assignment on Strategic Management Class in Universitas Tarumanegara Post Graduate class.
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Our mission is to discover new ways to improve and extend people’s lives. Our vision is to be a trusted leader in changing the practice of medicine.
Sun pharma- A complete company review, analysis of crisis and realistic recom...TilikaChawda
Sun pharma has been the most talked about Indian pharma company for being in the news several times for its unresolved issues with the US FDA regarding the Halol and Mohali plant.
This presentation has analysed the situation and it suggests various solutions for the same.
3 News Uptoday
35 New Guidance
42 Audit Findings
483 Observations
- Top Drug 483 Observations
46 EMA Non-Compliance Reports
- Wockhardt Limited, Aurangabad
- AGEPHA, Austria
- North China Pharmaceutical Group Semisyntech Co., Ltd, China
48 Regulations of the Month
- § 211.188 Batch production and control records
- § 211.192 Production record review
- § 211.194 Laboratory records.
To recap the previous month's pharma highlights, Monthly magazine Volume 19 has been released with the following content.
News Uptoday
New Guidance
Audit Findings
483 Observations (Millers of Wyckoff, Inc., NJ, - Producer of Sterile Drugs & InvaGen Pharmaceuticals, Inc., NY
Warning Letters (Pan Drugs Ltd., India & Jaychem Industries Ltd, New Zealand)
Health Canada Non Compliance Report (MS Pharma, Inc, Canada.)
WHO Notice of Concern (NOC)Report (Svizera Labs Private Limited, India)
Article of the Month - Warning Signs of a Weak Quality Culture
Regulations of the Month - Sec. 211.42 Design and construction features (c)(1) to (c)(4)
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. The Company’s lead products, ‘GeneType for Breast Cancer’ and ‘GeneType for Colorectal Cancer’, are clinically validated risk assessment tests that are first in their class. The Company signed a multi-year distribution agreement for its COVID-19 Risk Test and remains on track to launch its revolutionary Multi-Test, covering up to 70% of mortalities and morbidities, including major oncological, metabolic, and degenerative diseases. Genetic Technologies recent acquisition of EasyDNA has significantly accelerated the Company’s commercialization strategy, providing established revenue streams and direct-to-consumer marketing channels that include 70 websites in 40 countries. Listed on the ASX in 2000 and NASDAQ in 2005, Genetic Technologies has been a leader in the development and commercialization of genetic risk assessment technology for 20 years.
Genetic Technologies Limited is a diversified molecular diagnostics
company developing tools for the prediction and assessment of cancer
risk to help physicians proactively manage patient health. The
Company’s lead products, ‘GeneType for Breast Cancer’ and
‘GeneType for Colorectal Cancer’, are clinically validated risk
assessment tests that are first in their class. The Company’s
development pipeline includes new tests for COVID-19, Type 2
diabetes, cardiovascular disease, prostate cancer, and melanoma.
Listed on the ASX in 2000 and NASDAQ in 2005, Genetic
Technologies has been a leader in the development and
commercialization of genetic risk assessment technology for 20 years.
2. Index About Merck. Merck’s Programs. Today’s Merck. The Global Pharmaceutical Industry. Financial information.
3. About Merck global research-driven pharmaceutical company Originally founded in 1668 in Germany. Established in 1891 in U.S.A. Its commitment to help all patients obtain access to the Merck medicines they need.
4. Merck Programs Merck Patient Assistance Program. Free medicines. 1.5 million prescriptions. Medicines for chronic conditions. Merck Prescription Discount Program. For the uninsured. Saving of 15% to 20% off. Easy to access. Merck's HIV research Program. Merck Medical Outreach Program.
5. Merck's Contributionin Haiti Relief Efforts In response to this disaster. Initial contribution. Donating needed medicines. Participation on the ground.
7. From Laboratoryto Pharmacy Shelf Drug Discovery Preclinical Testing Investigational New Drug (IND) Application Clinical Trials Phase I Phase II Phase III Phase IV Approval Review
9. Current Strategies Merger with Schering-Plough. Job cuts follows the merger. Biotech medications. acquisition. ( Merck buys Avecia) Diversification. Innovation.
10. Risks Vioxx lawsuits issue. Withdrawn in 2004. 4 billion Settlement agreement charge. Certain of the Company’s products are going to lose patent protection.
11. Competitors COMPANY COUNTRY TOTAL REV M USD % R&D Switzerland 53,324 - 13% USA 48,371 – 1 6% BayerGermany 44,2 - 4% GlaxoSmithKline United Kingdom - 42,813 - 15% Johnson and Johnson USA 37,02 - 14% Sanofi-Aventis France 35,645 - 16% Switzerland 33,547 - 16% AstraZeneca UK/Sweden 26,475 - 15% Merck & Co. USA 22,636 - 21%
About Merck Merck is a global research-driven pharmaceutical company dedicated to putting patients first.Merck had originally founded in 1668 in Germany, and established in 1891 in U.S.A. and in its early years, we were selling medicines. Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that donate our medicines but help deliver them to the people who need them.
there are many programs in our company that help us to deliver medicines to people who need them, and these are some of them.in Merck Patient Assistance Program, we provided free medicines to whocould not afford them. Medicines for chronic conditions that affect millions – like diabetes, asthma and high blood pressure.In 2008, approximately 1.5 million prescriptions were filled under the Merck Patient Assistance Program. Merck Prescription Discount Program for the uninsured people, they can save from 15 to 20 % off and it is easy to access by filling a 1 page application. we have a research program for HIV, Merck and University of Cape Town and Tertiary School of Business Administration, have been in partnership since 2004 to implement an HIV and AIDS curriculum for students in underserved communities in Cape Town, South Africa.Merck Medical Outreach Program. Founded in 1958, and it is one of the ways Merck helps to expand access to medicines and vaccines, especially in the developing world.
Merck has made an initial contribution of $450,000 to assist relief efforts through many organizations such as project HOPE and the American Red Cross.We also are donating needed medicines through our Merck Medical Outreach Program.we also allowing our employees who are licensed health professionals or allied health services providers, to take one paid week and participate on the ground in Haiti with non-profit organizations
Our products: we cover many areas in pharmaceutical industry from vaccines, prescription products, Consumer Products and Animal Health.we have 15 different vaccines , 40 prescription products and 17 Consumer products and we offer a broad choice of vaccines, anti-infective and anti parasitic drugs for animal health.
as we mentioned before about drug discovery stages, after we get the approval from (FDA), we can proceed with other procedures such as piblishing, manufacturing and marketing and sales as you can see the value chain of the industry.
Today’s Merck: Merck and Schering-Plough recently merged to create a new company. Today, we are the second-largest pharmaceutical company in the world by market share. We also are a global leader in consumer products and animal care. Both Merck and Schering-Plough have a long and rich history of working in pharmaceutical industry. and we are enthusiastic about the future of this new companyour merger will helps improve research and development productivity and offer cost savings opportunities and new products to help companies manage through lean times. what happened is the CEO made a hard decision, to eliminate some of the duplication jobs. “We have taken the best from both companies, from a process standpoint and a people standpoint.” the CEO Clark statedBiotech medicationsLast December, Merck launched a new division called Merck BioVentures to make both new and follow-on, generic, biotech drugs. They are starting to show up in Europe, but are not yet allowed in the U.S.This is one of areas that Merck is targeting for growth. "At Merck we continue to execute on our strategy of expanding our biopharmaceutical expertise and manufacturing capacity.AcquisitionAvecia Biologics is a contract manufacturing organization with specific expertise in microbial-derived biologics. Financial details of the transaction were not disclosed.
Certain of the Company’s major products are going to lose patent protection in the near futureThe Company is dependent on its patent rights, and if its patent rights are invalidated, the business would be adversely affected. another fact that The Company’s products, including products in development, can not be marketed unless the Company obtains and maintains regulatory approval.
Roberto gallo, Litton industry, Nixon, Kissinger, bio weappon-
Roberto gallo, Litton industry, Nixon, Kissinger, bio weappon-